Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using 90Yttrium and 177Lutetium labeled somatostatin analogs: toxicity, response and survival analysis - Budiawan, H; Salavati, A; Kulkarni, H (Am J Nucl Med Mol Imaging, 2014)
et al.